CIRCULATING CELL-FREE DNA (CCFDNA) CONCENTRATIONS MEASURED BY CAPILLARY ELECTROPHORESIS: HIGH COST-EFFECTIVENESS IN DISCRIMINATING DLBCL PATIENTS AND ASSOCIATIONS WITH HIGH TUMOR BURDEN
Introduction: DLBCL is a malignancy with marked clinical, biological and prognostic heterogeneity. Its different outcomes may be predicted by the identification of molecular biomarkers. Therefore, quantification of circulating cell-free DNA (ccfDNA) and circulating tumor DNA (ctDNA) have emerged as...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-10-01
|
Series: | Hematology, Transfusion and Cell Therapy |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2531137923008313 |